Gabor Erdosi 🧩📄📊🧭 Profile picture
Oct 11, 2021 8 tweets 2 min read Read on X
Let me strip the unnecessary narrative out of this otherwise nice study/abstract to get a clear picture. Short thread 🧵

Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination
nature.com/articles/s4158…
How infection elicits broad protection
“SARS-CoV-2 infection produces B cell responses that continue to evolve for at least one year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern”
Following vaccination
“Between prime and boost, memory B cells produce antibodies that evolve increased neutralizing activity, but there is no further increase in potency or breadth thereafter.”
= the booster is too close to the priming dose and prevents affinity maturation.
“Instead, memory B cells that emerge 5 months after vaccination of naive individuals express antibodies that are similar to those that dominate the initial response.”
= original antigenic sin (OAS) kicks in, partly due to the prevented affinity maturation above.
“While individual memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination, the overall neutralizing potency of plasma is greater following vaccination”
=for a short period of time, quantity matches quality
“These results suggest that boosting vaccinated individuals with currently available mRNA vaccines will increase plasma neutralizing activity but may not produce antibodies with equivalent breadth to… convalescent individuals”
=in the future, you’re doomed to…
…poor quality immune responses, but your vaccine suppliers are happy to provide 2-3 boosters a year in an attempt to compensate quality with quantity.
TL;DR
Current vaccines are mediocre attempts, and beyond their stupid basic concept of injecting behind the mucosal barrier…,
…the regimen was also screwed up in a way that too big initial dose and a booster second dose administered way too early prevents proper maturation of immune responses. Although there’s no proper quality long term, you’re made to believe that quantity can overcome the problem.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Gabor Erdosi 🧩📄📊🧭

Gabor Erdosi 🧩📄📊🧭 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @gerdosi

Feb 18, 2023
Here I was called a COVID denier (what is that?), even though almost everything I stood for has been very close to reality since about March 2020. In fact, the only thing I was wrong about was the real world CFR of the virus. Back then I didn’t understand that poor management…
…was responsible for many deaths. Too early and unnecessary use of ventilators, too early and too high dose use of dexamethasone, remdesivir administration in hospitalized patients, avoidance of adding cheap and very low risk prophylactics, etc.
I only recognized these later.
I do remember when ventilator use was cut in half from one week to the other, following a protocol change in May 2020. Then I read this review from 2017 & realized that a lot more had been known about disease treatment than what was happening in hospitals. How could this happen?
Read 5 tweets
Feb 15, 2022
Dude either has no clue about what ‘immunity’ is, or has a very narrow tunnel view of it. Alternatively he’s deliberately spreading misinformation here.
NB, more typical courses have been:
Infection with Wuhan + Omicron
Infection with Alpha + Omicron
Infection with Wuhan + Delta + Omicron
Etc.
Guess how these typical scenarios fair against vaccination + Omicron? Yep, you’re absolutely right.
Immunology noobs question my assessments above.
Please consider that the study only looked at systemic humoral immunity and Ab binding to the spike protein. Then think about all the layers of immunity omitted from the analysis, e.g. innate, mucosal, T cells, to all antigens, etc.
Read 4 tweets
Dec 20, 2021
If you’re heading to the hospital with COVID make sure to declare that you’re allergic to remdesivir. It’s ineffective anyway.

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study kidney-international.org/article/S0085-… Text Shot: Our findings, ba...
While remdesivir is still touted as ‘safe and effecrive’ in the COVID response of many countries, public health officials start removing health insurance reimbursement for vitamins and minerals due to lack of efficacy shown… Could you make this up? businessinsider.co.za/medical-scheme…
My sad personal experience echoes this. theepochtimes.com/controversial-…
Read 4 tweets
Dec 10, 2021
‘Pandemic’ (changed by WHO in 2009)
‘Vaccine’ (changed by CDC in 2021, where kefir or vitamin D now fully qualify)
‘Peer reviewed’ (clueless people repeat it as mantra)
‘Breakthrough infection’ (if there’s robust immunity
‘T cells’ (ignored and ridiculed until Omicron appeared)
Oops, some editing issue at ‘peer reviewed’
If there’s robust immunity infecfion doesn’t occur. It only does if immunization was unsuccessful.
I think that we can safely add
‘hybrid immunity’
when it’s used as some superhuman state instead of natural immunity with repeated pathogen/antigen exposure.
Read 4 tweets
Dec 6, 2021
A recently developed method, that expresses full spike trimers, enables more accurate measurement of binding IgG1 antibodies. Quite a few interesting results in this study.
First of all, the second dose of mRNA vaccines adds very little extra binding. medrxiv.org/content/10.110…
More importantly, the absolute increase in Delta variant binding antibodies following administration of the 2nd dose to previously infected people is limited to a small subset of adults. At the same time, the relative number of Delta binding Ab to non-binding (old Wuhan) Ab is…
…terribly low. What’s the use of that thick soup of sky high antibodies then? Triggering autoimmunity? 🤔
The authors are not impressed either, although expected such results from shotgun injecting the same antigen, leaving no time for maturation.
Read 4 tweets
Aug 24, 2021
Antibody depending enhancement was a threat that looked possible (or even likely) a year ago, based on experience with historical CoV vaccine attempts. Then it started to look like a non-issue during trials and early rollout. Now it’s back on the table. First described in… 1/7
…a paper published in February, i.e. prior the emergence of Delta and only looking at Wuhan-Wuhan re-exposure. Enhancement was seen in just a small subset of macaques:
cell.com/cell/fulltext/…
Then a study that used a Wuhan-Delta sequence of spike exposure found something… 2/7
…really different👇🏻 journalofinfection.com/article/S0163-…
So what does that mean, what can we expect now that the 3rd doses of Wuhan spike based vaccines are being rolled out? The Original Antigenic Sin concept tells us that repeated exposure preferentially boosts old antibodies. (More… 3/7
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(